Get started
Author

Hege Elvebakken

Observed names: Elvebakken, H., Elvebakken, Hege, H. Elvebakken
Institution: Ålesund Hospital
ORCID: 0000-0001-7458-4836
Observed ORCID: 0000-0001-7458-4836
OpenAlex ID: A5029650411
A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations
2020 · Hege Elvebakken, Aurel Perren, et al. · Neuroendocrinology · 109
The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms
2021 · Venizelos, Andreas, Elvebakken, Hege, et al. · 77
Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study
2025 · Halfdan Sorbye, Geir Olav Hjortland, et al. · British Journal of Cancer · 43
PDF
Impact of KRAS and BRAF mutations on treatment efficacy and survival in high‐grade gastroenteropancreatic neuroendocrine neoplasms
2023 · Hege Elvebakken, Geir Olav Hjortland, et al. · Journal of Neuroendocrinology · 23
PDF
Treatment outcome according to genetic tumour alterations and clinical characteristics in digestive high-grade neuroendocrine neoplasms
2024 · Hege Elvebakken, Andreas Venizelos, et al. · British Journal of Cancer · 19
Mutation Spectrum in Liquid Versus Solid Biopsies From Patients With Advanced Gastroenteropancreatic Neuroendocrine Carcinoma
2023 · Stian Knappskog, Tobias Grob, et al. · JCO Precision Oncology · 19
Germline pathogenic variants in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms
2023 · Andreas Venizelos, Halfdan Sorbye, et al. · Endocrine Related Cancer · 17
PDF
Serum small RNAs in metastatic colorectal cancer predict response to chemotherapy and characterize high-risk patients
2024 · Robin Mjelle, Are K. Kristensen, et al. · Molecular Cancer · 8
PDF
Serum miRNA Signatures in Cancer Cachexia Depend on Systemic Inflammation
2025 · Terese Louise Schmidberger Karlsen, Robin Mjelle, et al. · Current Oncology · 3
PDF
Correction: Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study
2025 · Halfdan Sorbye, Geir Olav Hjortland, et al. · British Journal of Cancer · 3
PDF
Do older patients with colorectal cancer experience more deterioration in health-related quality of life than younger patients during the first year of palliative chemotherapy? A prospective real-world observational study
2024 · Ingunn Hatlevoll, Are K. Kristensen, et al. · Journal of Geriatric Oncology · 2
PDF
The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms
2023 · Andreas Venizelos, Hege Elvebakken, et al. · Endocrine Abstracts · 1
890MO Mutation spectrum in liquid versus solid biopsies from advanced digestive neuroendocrine carcinoma patients
2022 · H. Sorbye, S. Knappskog, et al. · Annals of Oncology · 1
1100MO Molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms
2021 · H. Sorbye, A. Venizelos, et al. · Annals of Oncology · 1
PDF
Mutational Landscape of 109 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms G3
2020 · Andreas Venizelos, Hege Elvebakken, et al. · Neuroendocrinology · 1
Genetic intratumour heterogeneity in digestive high‐grade neuroendocrine neoplasms
2026 · Siren Morken, Halfdan Sorbye, et al. · Journal of Neuroendocrinology
Young-onset colorectal cancer (YOCRC) in the nationwide precision oncology trial IMPRESS-Norway.
2026 · Sebastian Meltzer, Hege Elvebakken, et al. · Journal of Clinical Oncology
3137O IMPRESS-Norway: A nationwide precision-oncology study for off-label targeted therapies - Results from the first 1,740 patients
2025 · S. Brabrand, E.S. Samdal Steinskog, et al. · Annals of Oncology
Supplementary Material for: A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations
2020 · Elvebakken, H., Perren, A., et al. · Figshare
A Consensus Developed Morphological Re-evaluation of 196 Cases with Metastatic High-grade Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NEN G3) from the Nordic NEC Registries: Consequences for Classification, Treatment Response and Survival
2019 · Elvebakken, H., Perren, A., et al. · Research at the University of Copenhagen (University of Copenhagen)
Works count: 27
Citation count: 327
H-index: 8
I10-index: 7
Year
Topic
Type